Parkman Healthcare Partners LLC Amarin Corp Plcuk Transaction History

Parkman Healthcare Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$4.04 - $5.31 $469,278 - $616,798	-116,158 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$3.64 - $7.76 $36,243 - $77,266	-9,957 Reduced 7.9%	116,158 $489,000
Q2 2020 Aug 13, 2020	BUY	$4.78 - $8.26 $239,000 - $413,000	50,000 Added 65.69%	126,115 $873,000
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $238,244 - $1.28 Million	-59,561 Reduced 43.9%	76,115 $304,000
Q4 2019 Feb 13, 2020	BUY	$13.94 - $24.12 $1.89 Million - $3.27 Million	135,676 New	135,676 $2.91 Million

183

71.2M

183K

66.7K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $185M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.